2,705 results found

China's State Council issued new Anti-Monopoly Guidelines for the Pharmaceutical Sector (the "Guidelines") effective January 24, 2025.

The AML, like nearly all global antitrust laws, prohibits a company from using a dominant or monopoly position in a market to unfairly exclude competition or enhance its dominant position.

On 18 November 2008, the Chinese Ministry of Commerce (MOFCOM) announced that it has cleared the acquisition by InBev N.V./S.A. (InBev) of Anheuser Busch Companies Inc. (A-B), the largest transaction it has yet considered under China's new Anti-Monopoly Law (AML).

China's Anti-Unfair Competition Law ("AUCL") has been amended twice since its enactment in 1993, first in 2017 and another in 2019. On December 25, 2024...

The amendment for the 14-year-old Anti-Monopoly Law (AML) of China has finally been passed by the Standing Committee of the National People's Congress, coming into force on August 1, 2022.

On October 10, the Federal Trade Commission (FTC), after a 5-0 vote, issued a final rule amending the Premerger Notification Rules that implement the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act).

On 19 November 2019, the State Administration for Market Regulation ("SAMR") posted a draft.

If your company is working with Chinese manufacturers to produce goods or prototypes, you've likely encountered a non-disclosure agreement (NDA) along the way.

Common HR and operational risks, and offers actionable strategies to safeguard your business in China.

MOFCOM has announced its conditional clearance on MediaTek Inc's 4 billion USD acquisition of MStar Semiconductor Inc.

At the end of 2013 and in early 2014, the Chinese government issued a series of laws, regulations and policies on the regulation of private investment funds.

The entire Chinese economy, including its insurance industry, has experienced rapid growth in recent years.

Chinese companies are often quite reluctant to provide information or to fully cooperate with Western due diligence.

Overseas merger & acquisition (M&A) provides an effective approach for Chinese companies to embrace the global economy and diversify their portfolio across the world.

Following the rapid development of the SSE / SZSE and the ChiNext Market in China over recent years, an increasing number of judgments on the issue of misrepresentation relating to securities...

Financing is a critical consideration in M&A transactions. For a long period of time, financing large scale strategic M&As of listed companies in China has been a bottleneck. As such, it is important for companies to study successful M&A experiences from abroad and develop additional venues and tools for financing and venues for such transactions.

The large-scale shift to telework brought on by the COVID-19 pandemic is prompting businesses around the world to explore new avenues to engage with clients and friends.